Industry: Pharmaceuticals, Biotechnology
PPL Therapeutics is a biopharmaceutical company which is one of the world¡¯s leaders in the application of transgenic animal technologies to the development and production of human proteins for therapeutic and nutritional applications. PPL has a broad pipeline of diverse protein products including AAT, the Company¡¯s lead product, which is currently in Phase II clinical trials for cystic fibrosis. AAT is also under development for the treatment of congenital deficiency. PPL¡¯s other lead products are fibrinogen and bile salt stimulated lipase (BSSL). Transgenic production of human proteins involves the introduction of copies of human DNA into the genetic material of another ( www.ppl-therapeutics.com )
PPL Therapeutics plc
6 Berners Road
London N1 0PW
United Kingdom
Tel: +44 20 7704 9997
Fax: +44 20 7704 9998